Company Analysis

MaxCyte, Inc. (MXCT)

Nasdaq: MXCT · Services-Commercial Physical & Biological Research · Rockville, MD · filing with the SEC since 2004
Grade4.2
◀ Past 4.0● Present 4.7▶ Future 4.0
1 est.

Who runs MaxCyte, Inc.

Officers and directors as they report to the SEC on Forms 3, 4 and 5, named as filed
Chief executive, as filed
Masoud Maher
President and CEO. First filing Jul 2021, latest Mar 31, 2026, 3 filings in all.
Officers reporting now
3
of 11 people with a filing in the last fifteen months
Directors reporting now
8
20 people on the record since 2021
Officerssales are open-market, Sep 30, 2025 to Sep 30, 2026
NameTitle as filedFirst filingLatest filingSales, 12 months
Ahuja ParmeetChief Financial OfficerApr 2026Apr 17, 2026none
Masoud MaherPresident and CEOJul 2021Mar 31, 2026none
Swirsky Douglas JCHIEF FINANCIAL OFFICERMar 2023Mar 19, 20261 · $0.00
Directorssales are open-market, Sep 30, 2025 to Sep 30, 2026
NameRoleFirst filingLatest filingSales, 12 months
Al-Wakeel Yasir B.directorJul 2021Jun 22, 2026none
Balthrop Patrick JdirectorDec 2022Jun 22, 2026none
Brooke William WdirectorJul 2021Jun 22, 2026none
Collins CynthiadirectorOct 2024Jun 22, 2026none
Douglas RicharddirectorJul 2021Jun 22, 2026none
Erck Stanley CdirectorJul 2021Jun 22, 2026none
Hemrajani RekhadirectorJul 2021Jun 22, 2026none
Johnston John JosephdirectorJul 2021Jun 22, 2026none
Earlier names on the record13, newest filing first

A person is listed as reporting now after a filing in the last fifteen months. The record shows when someone last filed; it does not say why they stopped. Each name links to the filings on sec.gov.

SI Assistanton MXCT · research, not advice